Lynide 25mg Capsule Supplier USA | Pharmaceutical Exporter from India

Lynide 25mg Capsule: Specialized Lenalidomide Therapy for Hematological Cancers

Are you looking for a trusted Lynide 25 mg capsule exporter from India? Ernest Oncology, a dedicated division of Ernest Pharmaceutical Pvt. Ltd., is a leading global supplier and bulk distributor of advanced immunomodulatory treatments. We offer a high-authority, regulatory-compliant supply chain serving the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa, ensuring that critical oncology medications reach healthcare providers with pharmaceutical-grade integrity and efficient global logistics.

Detailed Product Overview: What is Lynide 25mg?

Lynide 25 mg is an oral capsule containing Lenalidomide, a potent immunomodulatory agent (IMiD). It is designed to treat and manage specific types of blood cancers and bone marrow disorders. Lynide works through a multifaceted mechanism, enhancing the body's natural immune response while simultaneously attacking cancer cells directly.

Lynide 25mg is clinically indicated for the management of:

1. Multiple Myeloma: Often used in combination with dexamethasone in patients who have received at least one prior therapy or as maintenance therapy following autologous stem cell transplantation.

2. Myelodysplastic Syndromes (MDS): Specifically for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality.

3. Mantle Cell Lymphoma (MCL): For patients whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.

4. Follicular Lymphoma & Marginal Zone Lymphoma: Used in combination with a rituximab product for previously treated patients.

Mechanism of Action: How Lynide 25mg Works:

Lynide (Lenalidomide) exerts its anti-tumor effects through three main pathways:

• Direct Anti-Tumor Activity: It induces cell cycle arrest and apoptosis (programmed cell death) in malignant cells by disrupting their internal signaling.

• Anti-Angiogenesis: It blocks the formation of new blood vessels that tumors need to grow and spread, effectively "starving" the cancer.

• Immunomodulation: It stimulates T-cells and Natural Killer (NK) cells, boosting the patient's own immune system to recognize and destroy abnormal cancer cells more effectively.

Administration and Safety Guidelines:

• Standard Dosage: The dose varies significantly based on the condition being treated (e.g., 25 mg once daily for Multiple Myeloma on specific cycle days).

• Instruction: Capsules should be swallowed whole with water at approximately the same time each day. Do not break, chew, or open the capsules.

• Food: Can be taken with or without food.

• REMS Program: Due to the risk of embryo-fetal toxicity, Lynide is typically distributed under a restricted distribution program (Risk Evaluation and Mitigation Strategy).

• Key Precautions: Pregnancy: Lenalidomide is structurally related to thalidomide and is known to cause severe birth defects. Effective contraception is mandatory for both men and women.

  • Blood Monitoring: Regular Complete Blood Counts (CBC) are required to monitor for neutropenia and thrombocytopenia.

Why Source Lynide 25 mg from Ernest Oncology?

• Direct Indian Exporter: Benefit from India’s position as a global pharmaceutical hub with access to GMP-certified Lynide 25 mg at competitive bulk pricing.

• Global Shipping Excellence: Proven expertise in exporting to the USA, UK, UAE, Australia, and South Africa. including all necessary documentation and temperature-controlled logistics.

• Bulk Supply Reliability: We maintain a consistent supply for oncology hospitals, wholesalers, and government procurement agencies to prevent treatment delays.

• B2B Partnership: We prioritize long-term relationships with international distributors, offering transparency and high-quality pharmaceutical support.